<DOC>
	<DOCNO>NCT00296153</DOCNO>
	<brief_summary>The purpose study evaluate effect Omacor 4g/day blood lipid parameter function stiffness blood vessel HIV infect patient Antiretroviral Therapy ( HAART )</brief_summary>
	<brief_title>Omacor Cardiovascular Risk Factors HIV Patients HAART Treatment</brief_title>
	<detailed_description>Results recent study show increase number Ischemic Heart Disease ( IHD ) incident among patient HAART treatment ( Highly Active Antiviral Therapy ) . Three element receive special attention : 1. immunodeficient effect HIV infection may influence progression arteriosclerosis 2. high level risk behaviour group patient ( i.e . high prevalence smoker group ) 3 . The HAART treatment increase plasma level cholesterol , LDL cholesterol triglyceride , result HIV related lipodystrophy . The cardioprotective effect n-3 PUFAs well establish epidemiological study small large clinical trial . Clinical trial show positive effect n-3 PUFA plasma triglyceride , statistically significant reduction cardiovascular death sudden cardiac death . Moreover n-3 PUFAs show beneficial effect endothelial function . Based rationale expect Omacor ( Omega-3-acid ethyl ester 90 ) positive effect risk factor related Ischemic Heart Disease HIV patient HAART treatment . Approximately 50 patient randomize Omacor 4 grams/day placebo . Treatment period 12 week .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Man/women &gt; 18 year age Documented HIV infection On active treatment HAART least 3 month . Written informed consent . This imply patient read understand Danish English Age &lt; 18 year Malign disease Patients assess cooperative Patients plan pregnant already pregnant breast feeding . Patients take fish oil capsule prior randomization . However , patient discontinue fish oil supplement least 8 week prior first visit include Patients allergic fish protein Statin treatment ongoing less three month , change statin treatment dose within last three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Human immunodeficiency Virus ( HIV )</keyword>
	<keyword>Highly Active Antiviral Therapy ( HAART )</keyword>
	<keyword>Ischemic Heart Disease</keyword>
	<keyword>OMACOR</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>